Donor mucosal immunocytes perpetuate refractory GVHD after intestinal transplantation without engrafting in recipient bone marrow: Case report and review of the literature. (22nd January 2019)

• Record Type: Journal Article
• Authors: Stanley, Kaitlin; Ranganathan, Sarangarajan; Mazariegos, George; Bond, Geoffrey; Soltys, Kyle; Ganoza, Armando; Jones, Katie; Cieply, Kathleen; Sindhi, Rakesh
• Is Part Of: Pediatric transplantation. Volume 23:Number 2(2019)
• Page Start: n/a
• Page End: n/a
• Publication Date: 2019-01-22
• Subjects: Transplantation of organs, tissues, etc. in children -- Periodicals; 617.95408305
• DOI: 10.1111/petr.13350
• Languages: English
• ISSNs: 1397-3142

Abstract

Abstract: GVHD as a complication of SOT presents both a diagnostic and therapeutic challenge. Typically affecting the skin, gastrointestinal tract, and liver, GVHD occurs when donor lymphocytes engrafted in recipient tissues are activated by host antigen‐presenting cells resulting in cytokine release and donor cell‐mediated cytotoxicity to host tissue. Here, we describe a 5‐year‐old girl who developed fatal, refractory GVHD after isolated intestinal transplantation when recipient immune cells failed to repopulate the allograft in the setting of CMV viremia. Persistence of the donor immune cells in the allograft mucosa, rather than engraftment in the recipient bone marrow, likely perpetuated this refractory GVHD. Early diagnosis and intervention are critical to reduce morbidity and mortality. Thus, periodic monitoring of peripheral blood and allograft mucosal chimerism with sensitive detection methods may allow early detection and potentially curative enterectomy in similar cases of refractory GVHD.